GOBLIN HOUSE
[ Enter Database → ]
Claim investigated: Federal database architecture lacks temporal disambiguation protocols to distinguish between historical acquired entities and current active entities sharing the same name, creating systematic identification vulnerabilities Entity: Invariant Original confidence: inferential Result: STRENGTHENED → SECONDARY
The claim is internally coherent and aligns with documented structural vulnerabilities in U.S. federal disclosure systems (e.g., absence of mandatory cross-database DUNS/UEI cross-referencing, separate LDA and FEC oversight silos). However, the supporting evidence is entirely secondary and inferential, with no primary-source documentation of an actual error caused by this architectural flaw. The claim's strongest case is that it correctly identifies a known structural gap. Its weakest case is that it overgeneralizes from a single entity search failure (Invariant) without proving that this failure caused a specific oversight miss. Until a concrete example is documented where a real entity exploited this ambiguity to evade disclosure, the claim remains a reasonable hypothesis, not an established finding.
Reasoning: Multiple secondary facts (facts 5, 6, 11-13, 15, 16, 18, 22, 25, 27, 29) consistently point to the same structural gap: the absence of integrated cross-referencing between corporate registries and federal disclosure databases. This convergence of independent secondary observations strengthens the inference that the vulnerability exists. However, the lack of a primary-source example of a real entity exploiting this gap prevents elevation to primary confidence. The claim's validity is consistent with known architectural design of USASpending, FEC, and LDA databases — each uses separate identifier systems (DUNS/UEI for contracts, contributor names for FEC, registrant names for LDA) with no required cross-validation.
DCRA (District of Columbia Department of Consumer and Regulatory Affairs): Entity name: 'Invariant LLC' — exact search by corporate name
If Invariant LLC is incorporated in D.C., its articles of organization, registered agent, and principal officers would be publicly available — resolving the entity identification question definitively at the state level.
SEC EDGAR: Stagwell Inc. (CIK 0001834960) — all 10-K and 10-Q filings from 2020-2025; search within for 'Invariant'
Would confirm or deny the parent-subsidiary relationship between Stagwell and Invariant. If Invariant is a Stagwell subsidiary, it must appear in Stagwell's consolidated financial statements (Schedule 21 for 10-K). If not listed, the claimed relationship is false.
FEC: Schedule A for DCCC and DSCC reports: search for bundled contributions from 'Invariant' or any affiliated PACs/individuals in the years referenced (2024-2026)
Would directly confirm or falsify the $2.5M, $2.9M, and $4M bundling claims. If these contributions exist, the underlying donors would be disclosed under 52 U.S.C. § 30104(i).
Lobbying Disclosure Act (LDA) database (via Senate Office of Public Records): Registrant name: 'Invariant LLC' — all LD-2 quarterly reports for 2023-2025, checking for Palantir and SpaceX as clients
Would directly verify the $560K Palantir lobbying claim and confirm whether Invariant actually registered as a lobbyist for these clients.
USASpending.gov: Search by entity name 'Invariant' with all variations (legal business name, DBA, parent). Also search by Palantir and SpaceX contract reference numbers.
If Invariant has federal contracts, they must appear here. Their absence (as noted) suggests either no contracts or an alternate legal name.
SIGNIFICANT — If confirmed, this structural vulnerability in federal databases would represent a systematic gap in campaign finance and lobbying oversight that could allow entities to fragment their regulatory footprint. The claim's significance is limited by its current inferential status; it would become critical with primary-source documentation of a specific evasion case. The underreported angle of generic-name exploitation as a distinct regulatory arbitrage strategy has not been addressed by GAO or congressional oversight.